Flanagan W. Michael
Chief Scientific Officer at Avidity Biosciences, Inc.
- Sold, on record
- $13.5M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jan 21, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Avidity Biosciences, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Avidity Biosciences, Inc.RoutineDec 18 2024
Sold 12,742 shares at $32.66 ($416k)
Flanagan W. Michael, CSTO
10b5-1 planSold 14.9% of holdings ($2.8M position)72,647 shares left0.5x usual sizeFiling
- 2 Form 4 sale Avidity Biosciences, Inc.RoutineJan 21 +34 days
Sold 5,672 shares at $28.60 ($162k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 5.8% of holdings ($2.8M position)91,975 shares left0.2x usual sizeFiling
- 3 Form 4 sale Avidity Biosciences, Inc.RoutineMar 11 +49 days
Sold 20,000 shares at $30.13 ($603k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 17.9% of holdings ($3.4M position)91,975 shares left1.1x usual sizeFiling
- 4 Form 4 sale Avidity Biosciences, Inc.RoutineMar 20 +9 days
Sold 11,780 shares at $31.06 ($366k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 12.8% of holdings ($2.9M position)80,195 shares left0.6x usual sizeFiling
- 5 Form 4 sale Avidity Biosciences, Inc.RoutineJun 11 +83 days
Sold 20,000 shares at $32.88 ($658k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 20% of holdings ($3.3M position)80,195 shares left1.2x usual sizeFiling
- 6 Form 4 sale Avidity Biosciences, Inc.RoutineSep 11 +92 days
Sold 20,000 shares at $38.94 ($779k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 20% of holdings ($3.9M position)80,195 shares left1x usual sizeFiling
- 7 Form 4 sale Avidity Biosciences, Inc.RoutineJan 7 +118 days
Sold 2,373 shares at $72.23 ($171k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 2.5% of holdings ($6.8M position)91,627 shares left0.1x usual sizeFiling
- 8 Form 4 sale Avidity Biosciences, Inc.RoutineJan 21 +14 days
Sold 6,534 shares at $72.45 ($473k)
Flanagan W. Michael, Chief Scientific Officer
10b5-1 planSold 7.1% of holdings ($6.6M position)85,093 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 6,534 | $473k | 7.1% | Routine | SEC |
| Jan 7, 2026 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 2,373 | $171k | 2.5% | Routine | SEC |
| Sep 11, 2025 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 20,000 | $779k | 20.0% | Routine | SEC |
| Jun 11, 2025 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 20,000 | $658k | 20.0% | Routine | SEC |
| Mar 20, 2025 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 11,780 | $366k | 12.8% | Routine | SEC |
| Mar 11, 2025 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 20,000 | $603k | 17.9% | Routine | SEC |
| Jan 21, 2025 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 5,672 | $162k | 5.8% | Routine | SEC |
| Dec 18, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 12,742 | $416k | 14.9% | Routine | SEC |
| Dec 11, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 24,000 | $858k | 21.9% | Routine | SEC |
| Dec 11, 2024 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 24,000 | $866k | Notice | SEC | |
| Oct 1, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 62,500 | $3M | 42.3% | Unusual | SEC |
| Sep 23, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 25,000 | $1.1M | 22.6% | Routine | SEC |
| Sep 11, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 111,394 | $4.5M | 64.7% | Routine | SEC |
| Jun 18, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 10,106 | $395k | 16.6% | Routine | SEC |
| Jan 22, 2024 | Avidity Biosciences, Inc. | CSTO | Form 4 sale | 4,129 | $42k | 10.3% | Routine | SEC |